Selenoproteins in Tumorigenesis and Cancer Progression.

Short SP, Williams CS
Adv Cancer Res. 2017 136: 49-83

PMID: 29054422 · PMCID: PMC5819884 · DOI:10.1016/bs.acr.2017.08.002

Selenium is a micronutrient essential to human health and has long been associated with cancer prevention. Functionally, these effects are thought to be mediated by a class of selenium-containing proteins known as selenoproteins. Indeed, many selenoproteins have antioxidant activity which can attenuate cancer development by minimizing oxidative insult and resultant DNA damage. However, oxidative stress is increasingly being recognized for its "double-edged sword" effect in tumorigenesis, whereby it can mediate both negative and positive effects on tumor growth depending on the cellular context. In addition to their roles in redox homeostasis, recent work has also implicated selenoproteins in key oncogenic and tumor-suppressive pathways. Together, these data suggest that the overall contribution of selenoproteins to tumorigenesis is complicated and may be affected by a variety of factors. In this review, we discuss what is currently known about selenoproteins in tumorigenesis with a focus on their contextual roles in cancer development, growth, and progression.

© 2017 Elsevier Inc. All rights reserved.

MeSH Terms (10)

Animals Antioxidants Carcinogenesis Disease Progression Humans Neoplasms Oxidation-Reduction Oxidative Stress Selenium Selenoproteins

Connections (1)

This publication is referenced by other Labnodes entities: